{"id":3782,"date":"2014-09-30T18:01:28","date_gmt":"2014-09-30T16:01:28","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=3782"},"modified":"2014-09-30T18:01:28","modified_gmt":"2014-09-30T16:01:28","slug":"farmaci-spesa-pubblica","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmaci-spesa-pubblica\/","title":{"rendered":"The sustainability of medicines in public spending"},"content":{"rendered":"<p><i>Current Italian public health expenditure is among the lowest in Europe. There\u00a0<strong>pharmaceutical expense<\/strong>\u00a0is continuously declining, in 2013 equal to 7% of global public health expenditure. is on the rise\u00a0<strong>sharing expense<\/strong>\u00a0of citizens.<\/i><\/p>\n<p><a title=\"View all articles in Health\" href=\"http:\/\/www.benesseresalute.net\/sostenibilita-farmaci-spesa-pubblica-5759\/\" target=\"_blank\" rel=\"noopener\">Written by Alessandra and inserted in Salute on 09\/30\/14<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" alt=\"\" src=\"http:\/\/www.nicocongressi.it\/wp-content\/fancygallery\/Nico%20Congressi\/ASIAM\/thumbs\/1314017196_cena2.jpeg\" width=\"170\" height=\"180\" \/>The <a href=\"http:\/\/video.gelocal.it\/\" target=\"_blank\" rel=\"noopener\">I agree HEAR<\/a> held in Ivrea was an opportunity to make a point on the sustainability of medicines in Italian public spending. The cardiologist and professor Francesco Vittorio Costa spoke on the subject, commenting on the data, which see the current Italian public health expenditure among the lowest in Europe, in 2012 it was equal to 7% of GDP, against 9% in France and 8.7% in Germany. There\u00a0<strong>pharmaceutical expense<\/strong>\u00a0is continuously declining, in 2013 equal to 7% of global public health expenditure. It is surprising that Germany, a European welfare model, has much higher pharmaceutical expenditure than in Italy, however it must be borne in mind that in Germany there is a high percentage of prescriptions for generic drugs which cost more than in Italy .<br \/>\nPublic pharmaceutical expenditure is decreasing but the\u00a0<strong>sharing expense<\/strong>\u00a0of citizens: from 0.98 billion in 2010 to 1.44 billion in 2013.<\/p>\n<p>As far as cardiovascular pathologies are concerned, the cost of drugs is a secondary item because what costs are the events that lead to hospitalizations. Hospital costs account for 73% of total coronary heart disease costs, 94% of stroke costs, and approximately 80% of heart failure costs. The benefits of one<strong> constant therapy<\/strong>\u00a0they certainly help in the success of the treatment. It is therefore necessary to reverse course and think of drugs as a useful investment to reduce future expenses, such as hospital expenses, but above all, to improve the health of patients, which is possible with prevention.<\/p>\n<p>Related news: <a href=\"http:\/\/www.benesseresalute.net\/farmaci-generici-convenienza-salute-5741\/\" target=\"_blank\" rel=\"noopener\">Generic drugs: convenience doesn&#039;t always rhyme with health<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>La spesa sanitaria pubblica corrente italiana tra le pi\u00f9 basse d\u2019Europa. La\u00a0spesa farmaceutica\u00a0\u00e8 in continuo calo, nel 2013 pari al 7% della spesa sanitaria pubblica globale. \u00e8 in aumento la\u00a0spesa di compartecipazione\u00a0dei cittadini. Scritto da Alessandra e inserito in\u00a0Salute\u00a0il 30\/09\/14 Il convengo AUDITA tenutosi ad Ivrea \u00e8 stata l\u2019occasione per fare un punto sulla sostenibilit\u00e0 &hellip;<\/p>","protected":false},"author":4,"featured_media":642,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[29,26],"class_list":["post-3782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-prezzo-farmaci","tag-spesa-farmaceutica"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/3782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=3782"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/3782\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/642"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=3782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=3782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=3782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}